‘Meta-analysis’ Of Early Breast Cancer Trials finds Adjuvant Therapy Significantly Prolongs Life
In Brief: McDonnell Foundation Awards Four Fellowships; UCLA’s Kenneth Shine Is Next IOM President
FDA Urges Moratorium On Sale, Use of Silicone Breast Implants
NCI TO Issue RFA For Gene Therapy Studies; $20 Mil. Se-Aside Ok’d
FASEB Says NIH Budge Should Reach $10 Bil. In Fiscal 1993
Miami HIV Trials Unit Forced To Turn Some Patients Away
AIDS Research Loan Repayment Program
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ









